Elos Medtech マネジメント

マネジメント基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Stefano Alfonsi

最高経営責任者

SEK 500.0k

報酬総額

CEO給与比率	n/a
CEO在任期間	1.3yrs
CEOの所有権	n/a
経営陣の平均在職期間	2.1yrs
取締役会の平均在任期間	2.2yrs

経営陣の近況

Recent updates

The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

Feb 28

Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Feb 24

Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

Feb 11

When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

Jan 31

How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Jan 18

Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

Jan 06

Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Dec 26

Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Dec 13

Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 30

Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 17

CEO（最高経営責任者

Stefano Alfonsi (59 yo)

1.3yrs

在職期間

SEK 500,000

報酬

Mr. Stefano Alfonsi serves as Director at Elos Medtech AB (publ) since December 2021 and serves as CEO & President since September 05, 2022. He served as Chairman at Elos Medtech AB (publ) from May 03, 202...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Stefano Alfonsi	CEO, President & Director	1.3yrs	SEK 500.00k	データなし
Ewa Linsater	Chief Financial Officer	4.5yrs	データなし	0.0071% SEK 405.8k
Monica Tapper	Chief People Officer	1.8yrs	データなし	データなし
Soren Olesen	Chief Commercial & Operations Officer Dental	1.9yrs	データなし	データなし
Tina Friis-Poulsen	Managing Director of Elos Medtech in Gorlose	2.9yrs	データなし	データなし
Jodie Gilmore	Chief Commercial & Operations Officer Orthopedics	2.9yrs	データなし	データなし
Conny Jakobsson	Managing Director of Elos Medtech Tianjin Co. Ltd.	1.8yrs	データなし	データなし
Sam Svännel	Managing Director of Elos Medtech in Timmersdala & Skara	2.1yrs	データなし	データなし
Tim Turner	Managing Director of Elos Medtech in Memphis	2.9yrs	データなし	データなし
Mathias Andersson	Chief Executive Officer of Elos Medtech Microplast AB	no data	データなし	データなし

2.1yrs

平均在職期間

56.5yo

平均年齢

経験豊富な経営陣: ELOS Bの経営陣は経験豊富であると考えられます ( 2.1年の平均在職年数)。

取締役

名称	ポジション	在職期間	報酬	所有権
Stefano Alfonsi	CEO, President & Director	2yrs	SEK 500.00k	データなし
Birker Bahnsen	Director	2.3yrs	データなし	データなし
Lovisa Lander Widengren	Director	2.3yrs	データなし	データなし
Magnus Rene	Independent Chairman of the Board	1.6yrs	SEK 417.00k	データなし
Alexander Cicetti	Director	2.3yrs	データなし	データなし
Winfried Schaller	Independent Director	less than a year	データなし	データなし

2.2yrs

平均在職期間

58yo

平均年齢

経験豊富なボード: ELOS Bの取締役会は経験豊富ではない ( 2.2年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Elos Medtech マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Elos Medtech AB (Publ) Elects Winfried Schaller as Board Member

No independent directors

Elos Medtech AB Announces Nomination Committee Appointments

Elos Medtech AB (Publ) Announces Management Changes

Elos Medtech AB (Publ) Announces Management Changes

Less than half of directors are independent

Recent updates

Elos Medtech AB (publ) (OM:ELOS B) acquired Klingel Holding GmbH from IK Partners and Management.

Nasdaq Stockholm Approves Elos Medtech's Application for De-Listing

Elos Medtech Applies for De-Listing from Nasdaq Stockholm

New major risk - Shareholder dilution

Elos Medtech AB (publ) to Report Fiscal Year 2024 Results on Feb 28, 2025

Third quarter 2023 earnings released

Elos Medtech AB (publ) (OM:ELOS B) entered an agreement to acquire KLINGEL medical metal GmbH from IK Partners and Management for an enterprise value of €370 million.

New minor risk - Profit margin trend

Second quarter 2023 earnings released

Investor sentiment improves as stock rises 20%

Elos Medtech AB (Publ) Elects Winfried Schaller as Board Member

First quarter 2023 earnings released

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: kr9.31 (vs kr9.37 in FY 2021)

No independent directors

Elos Medtech AB (publ) to Report Q3, 2023 Results on Oct 19, 2023

Third quarter 2022 earnings released

Elos Medtech AB Announces Nomination Committee Appointments

Elos Medtech AB (Publ) Announces Management Changes

Elos Medtech AB (Publ) Announces Management Changes

Second quarter 2022 earnings released

Elos Medtech AB (publ) Omits Dividend for the Year 2021

First quarter 2022 earnings: Revenues miss analyst expectations

Less than half of directors are independent

Elos Medtech AB (publ)(OM:ELOS B) dropped from OMX Nordic Small Cap Index

Chief Financial Officer recently sold kr159k worth of stock

Chief Financial Officer recently sold kr159k worth of stock

Investor sentiment improved over the past week

Third quarter 2021 earnings released

Investor sentiment deteriorated over the past week

Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Independent Director recently sold kr848k worth of stock

Second quarter 2021 earnings released: EPS kr2.28 (vs kr0.85 in 2Q 2020)

TA Associates Management, L.P. through its funds Ta Xiii-B, L.P., Ta Xiii-A, L.P. and TA Investors XIII, L.P. made an offer to acquire Elos Medtech AB (publ) (OM:ELOS B) from a group of sellers for SEK 1.7 billion.

Elos Medtech in Talks of Possible Takeover Bid

Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?

Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock

First quarter 2021 earnings released

Upcoming dividend of kr1.50 per share

Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)

We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

President & CEO recently sold kr801k worth of stock

Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?

New 90-day high: kr121

The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

President & CEO recently bought kr233k worth of stock

Revenue and earnings miss expectations

Full year 2020 earnings released: EPS kr4.46 (vs kr4.77 in FY 2019)

Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

New 90-day high: kr117

When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Elos Medtech AB (publ) Announces Executive Changes

Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

New 90-day high: kr109

Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

New 90-day high: kr98.80

Third-quarter earnings released: Revenue and earnings beat expectations

Third quarter earnings released

Elos Medtech AB (publ) to Report Q3, 2021 Results on Oct 20, 2021

New 90-day high - kr89.60

マネジメント基準チェック /24